Td Asset Management Inc Igm Biosciences, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 164,472 shares of IGMS stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

164,472

Previous 164,472 -0.0%

Holding current value

$1.61 Million

Previous $1.13 Million 140.92%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$6.51 - $11.47 $34,828 - $61,364	5,350 Added 3.36%	164,472 $1.13 Million
Q1 2024 May 08, 2024	BUY	$8.68 - $17.36 $656,815 - $1.31 Million	75,670 Added 90.67%	159,122 $1.54 Million
Q3 2023 Oct 27, 2023	BUY	$6.66 - $10.64 $277,895 - $443,964	41,726 Added 100.0%	83,452 $696,000
Q2 2023 Aug 09, 2023	BUY	$8.86 - $14.0 $202,300 - $319,662	22,833 Added 120.85%	41,726 $385,000
Q1 2023 May 10, 2023	SELL	$13.74 - $25.76 $187,770 - $352,036	-13,666 Reduced 41.97%	18,893 $259,000
Q1 2022 May 10, 2022	SELL	$13.42 - $29.73 $234,474 - $519,442	-17,472 Reduced 34.92%	32,559 $870,000
Q4 2021 Feb 10, 2022	BUY	$27.59 - $66.39 $241,274 - $580,580	8,745 Added 21.18%	50,031 $1.47 Million
Q3 2021 Nov 09, 2021	BUY	$65.76 - $90.65 $361,680 - $498,575	5,500 Added 15.37%	41,286 $2.72 Million
Q2 2021 Aug 11, 2021	SELL	$57.98 - $96.6 $152,023 - $253,285	-2,622 Reduced 6.83%	35,786 $2.43 Million
Q1 2021 May 14, 2021	BUY	$71.56 - $121.23 $587,292 - $994,934	8,207 Added 27.17%	38,408 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $451,675 - $1.1 Million	9,527 Added 46.08%	30,201 $2.67 Million
Q3 2020 Nov 10, 2020	SELL	$43.0 - $84.01 $180,600 - $352,842	-4,200 Reduced 16.89%	20,674 $1.53 Million
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $66,690 - $97,772	1,300 Added 5.51%	24,874 $1.82 Million
Q1 2020 May 15, 2020	SELL	$31.51 - $73.75 $163,852 - $383,500	-5,200 Reduced 18.07%	23,574 $1.32 Million
Q3 2019 Nov 07, 2019	BUY	$17.75 - $24.3 $510,738 - $699,208	28,774 New	28,774 $511,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $283M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Igm Biosciences, Inc. Transaction History